FDA Roundup: Soliris Biosimilar, Nonerosive GERD Treatment
Check out important updates from the FDA from over the past week.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
With FDA Approval, Vonoprozan Offers Options for Nonerosive GERD
The approval offers a first of its kind treatment option for patients living with nonerosive GERD.
Podcast: Pharmacy Financing With First Financial Bank
Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.
Novo Nordisk Once-Weekly Insulin Faces Approval Setback With CRL
Had Novo Nordisk’s insulin icodec secured FDA approval, it would have been the first and only once-weekly basal insulin option for adults with diabetes.
FDA Approves Roflumilast Cream 0.15% for Atopic Dermatitis in Pediatric, Adult Patients
The commercial product is expected to be available by the end of July.